Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-268-9 | CAS number: 105-08-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
1,4-Cyclohexanedimethanol is an isomeric mixture of about of 70 % trans- and 30 % cis-isomers. The metabolic fate and disposition of the test material was investigated in a non-guideline study conducted according to generally acceptable scientific standards of the time. In one phase of the study, groups of four adult male or female Charles River CD-COBS rats received a single dose of 40 (males only) or 400 (both sexes) mg/kg bw [14C] 1,4-cyclohexanedimethanol by oral gavage. Urine, feces and expired air were collected for 48 hours. At necropsy, brain, heart, lung, kidney, fat, liver and carcasses were processed for radioactivity. The test material was rapidly absorbed, metabolized and eliminated with most of the radioactivity recovered in urine (89-96%), feces (1.2-3.0%), and cage washings (1.02-6.61%) by 48 hours. Up to 73% of the dose was excreted in urine by 4 hours. Respiratory [14C] CO2 accounted for only 0.01-0.05% of the dose. Less than 0.5% of the administered radioactivity was retained in the tissues, organs and carcass. Total radioactivity recovered accounted for 97.9-99.7% of the dose. Total excretion of radioactivity did not appear to be dose or sex related; however, females exhibited a slightly slower excretion rate than males but this may be related to the differences in radioactivity recovered in the cage washes. Urine from this phase of the study was treated under a variety of conditions to characterize and identify metabolites.
To determine the half life of 1,4-cyclohexanedimethanol in blood, additional groups of 3-4 male rats were administered 400 mg/kg bw of non-radioactive test material by oral gavage and blood samples were removed at 0.25- 4 hours after dosing. Blood plasma was extracted with diethyl ether to characterize and identify blood metabolites. Metabolites in blood and urine were identified by flame ionization gas chromatography and gas chromatography-mass spectrometry. In addition to the parent compound 1,4-cyclohexanedimethanol (both cis- and trans-isomers), cis- and trans-isomers of 4-hydroxymethylcyclohexanecarboxylic acid were detected in the blood. The half-life of 1,4-cyclohexanedimethanol in blood from male rats dosed with 400 mg/kg bw of the test material was about 13 minutes. Unchanged 1,4-cyclohexanedimethanol was not detected in the urine. The major metabolites identified in the urine were cyclohexanedicarboxylic acid (68%) and 4-hydroxymethylcyclohexanecarboxylic acid (31%). The cis-trans ratio of the metabolites excreted in the urine was the same as the ratio of the original dose. Less than 2% of the radioactivity in urine was not fully characterized.
The metabolic pathway for 1,4-cyclohexanedimethanol appears to consist of a series of oxidation reactions that ultimately yield cyclohexanedicarboxylic acid. Methanol groups on the parent compound appear to be oxidized to aldehyde groups which are further oxidized to carboxyl groups. The partial oxidation product, 4-hydroxymethylcyclohexanecarboxylic acid, was identified in both urine and blood while the terminal oxidation product, cyclohexanedicarboxylic acid, was identified in the urine. Urinary ether extraction studies suggest a small amount of radioactivity may be attributed to a glycine conjugate of one or more of the oxidation products of 1,4-cyclohexanedimethanol.
The results of this study indicate that, at dose levels up to 400 mg/kg bw, orally administered 1,4-cyclohexanedimethanol is rapidly absorbed from the gastrointestinal tract, metabolized, and excreted by male and female rats. Almost all of the orally administered radiolabeled material was excreted in the urine by 48-hours with small amounts recovered in feces and expired air. Less than 0.5% of the dose was retained in the tissues and carcass. Based on the study results, 1,4-cyclohexanedimethanol has a low potential to bioaccumulate.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.